Ferrer Internacional SA

Barcelona, Spain

Ferrer Internacional SA

Barcelona, Spain

Time filter

Source Type

Patent
Ferrer Internacional S.A. | Date: 2017-06-07

The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in a manner to minimize interaction of acetylsalicylic acid with the statin, for use in the prevention or treatment of cardiovascular diseases.


Patent
Ferrer Internacional S.A. | Date: 2014-06-05

The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in a manner to minimize interaction of acetylsalicylic acid with the statin, for use in the prevention or treatment of cardiovascular diseases.


The invention provides a compound of formula (I)_(1)-R_(4) represent different meanings, and pharmaceutically acceptable salts thereof. The invention also provides synthetic procedures for preparing the compounds of formula (I), pharmaceutical compositions comprising them, their use as medicaments, their use as therapeutic active substances for the treatment of conditions mediated by agonizing the orexin 2 receptor, and their use as therapeutic active substances for the treatment of narcolepsy, excessive daytime sleepiness, nighttime insomnia, depression, sleep apnea and jet lag, for promoting wakefulness and emergence from anesthesia, and for preventing diet-induced obesity.


The invention provides novel halogenated pyrazolo[1,5-a]pyrimidines of formula (I) wherein R, R_(1), X and Y have different meanings, and pharmaceutically acceptable salts thereof. Compounds of formula (I) are useful for treating or preventing anxiety, epilepsy and sleep disorders including insomnia, and for inducing sedation-hypnosis, anesthesia, sleep and muscle relaxation. The invention also provides synthetic procedures for preparing said compounds and certain intermediates, as well as intermediates themselves.


Patent
Ferrer Internacional S.A. | Date: 2013-03-20

The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.


Patent
Ferrer Internacional S.A. | Date: 2015-10-14

The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.


Patent
Ferrer Internacional S.A. | Date: 2014-03-05

The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.


Patent
Ferrer Internacional S.A. | Date: 2014-12-10

The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in a manner to minimize interaction of acetylsalicylic acid with the statin, for use in the prevention or treatment of cardiovascular diseases.


Patent
Ferrer Internacional S.A. | Date: 2016-05-04

The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.


Patent
Ferrer Internacional S.A. | Date: 2012-04-04

The invention relates to an ovule for vaginal administration of arasertaconazole mononitrate consisting of arasertaconazole mononitrate, colloidal silica and a fatty base.

Loading Ferrer Internacional SA collaborators
Loading Ferrer Internacional SA collaborators